Hypogonadism T2dm Prediabetes Overweight Obesity clinical trials

Explore recruiting hypogonadism t2dm prediabetes overweight obesity clinical trials.

Recruiting hypogonadism t2dm prediabetes overweight obesity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypogonadism T2dm Prediabetes Overweight Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 52 week prospective randomized controlled study to investigate the effect of intramuscular testosterone undecanoate supplementation vs placebo on intrahepatic fat content in obese men with uncontrolled type 2 diabetes (T2DM) suffering from hypogonadism with a subsequent 108 week open label phase to investigate long term effects on lipid distribution and cardiometabolic parameters in all participating men.

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Hypogonadism T2dm Prediabetes Overweight Obesity trials by city

Hypogonadism T2dm Prediabetes Overweight Obesity in Toronto Hypogonadism T2dm Prediabetes Overweight Obesity in Vancouver Hypogonadism T2dm Prediabetes Overweight Obesity in Montreal Hypogonadism T2dm Prediabetes Overweight Obesity in Calgary Hypogonadism T2dm Prediabetes Overweight Obesity in Edmonton Hypogonadism T2dm Prediabetes Overweight Obesity in Ottawa Hypogonadism T2dm Prediabetes Overweight Obesity in Winnipeg Hypogonadism T2dm Prediabetes Overweight Obesity in Quebec City Hypogonadism T2dm Prediabetes Overweight Obesity in Hamilton Hypogonadism T2dm Prediabetes Overweight Obesity in Kitchener Hypogonadism T2dm Prediabetes Overweight Obesity in London Hypogonadism T2dm Prediabetes Overweight Obesity in Halifax Hypogonadism T2dm Prediabetes Overweight Obesity in New York Hypogonadism T2dm Prediabetes Overweight Obesity in Los Angeles Hypogonadism T2dm Prediabetes Overweight Obesity in Chicago Hypogonadism T2dm Prediabetes Overweight Obesity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease